标题
New perspectives on CKD-induced dyslipidemia
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 21, Issue 10, Pages 967-976
出版商
Informa UK Limited
发表日期
2017-08-22
DOI
10.1080/14728222.2017.1369961
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism
- (2017) Hua Chen et al. JOURNAL OF PROTEOME RESEARCH
- Metabolomics for clinical use and research in chronic kidney disease
- (2017) Berthold Hocher et al. Nature Reviews Nephrology
- The link between phenotype and fatty acid metabolism in advanced chronic kidney disease
- (2017) Dan-Qian Chen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease
- (2017) Dan-Qian Chen et al. Redox Biology
- Metabolic biomarkers for chronic kidney disease
- (2016) Marc Breit et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease
- (2016) Lidia Anguiano et al. ATHEROSCLEROSIS
- Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
- (2016) Gissette Reyes-Soffer et al. CIRCULATION
- A combined non-targeted and targeted metabolomics approach to study the stereoselective metabolism of benalaxyl enantiomers in mouse hepatic microsomes
- (2016) Xinru Wang et al. ENVIRONMENTAL POLLUTION
- Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?
- (2016) Anna Gluba-Brzózka et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease
- (2016) Hirokazu Honda et al. Journal of Atherosclerosis and Thrombosis
- Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans
- (2016) Zhi-Hao Zhang et al. JOURNAL OF PROTEOME RESEARCH
- Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study
- (2016) Barbara Kollerits et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Dyslipidemia in patients with chronic kidney disease
- (2016) Matthew R. Hager et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- The Patterns, Risk Factors, and Prediction of Progression in Chronic Kidney Disease: A Narrative Review
- (2016) David Collister et al. SEMINARS IN NEPHROLOGY
- Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients
- (2016) Hao Shen et al. BMC Nephrology
- Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins
- (2016) Nans Florens et al. Toxins
- Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression
- (2016) Hua Chen et al. Redox Biology
- Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases
- (2015) Valvanera Fernández-Laso et al. ATHEROSCLEROSIS
- Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference
- (2015) Marisa Martín et al. ATHEROSCLEROSIS
- Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease
- (2015) Clara Barrios et al. ATHEROSCLEROSIS
- Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD
- (2015) M. Gracia et al. Clinical Journal of the American Society of Nephrology
- Dialysis Modalities and HDL Composition and Function
- (2015) M. Holzer et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- HDL particle number and size as predictors of cardiovascular disease
- (2015) Anatol Kontush Frontiers in Pharmacology
- Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis and Nrf2 dysfunction in aristolochic acid-induced nephropathy
- (2015) Ying-Yong Zhao et al. Scientific Reports
- UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry
- (2014) Ying-Yong Zhao et al. CLINICAL BIOCHEMISTRY
- HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype
- (2014) R. Shroff et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient
- (2014) Christoph Wanner et al. KIDNEY INTERNATIONAL
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study
- (2014) A. Betriu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study
- (2014) David Arroyo et al. BMC Nephrology
- Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
- (2013) Stanley Ip ANNALS OF INTERNAL MEDICINE
- Clinical and research markers of oxidative stress in chronic kidney disease
- (2013) Patrick Steven Tucker et al. BIOMARKERS
- Metabolomics in chronic kidney disease
- (2013) Ying-Yong Zhao CLINICA CHIMICA ACTA
- Lipoprotein metabolism and CKD: overview
- (2013) Philip Barter Clinical and Experimental Nephrology
- Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management
- (2013) Sudarshan Balla et al. CURRENT OPINION IN PHARMACOLOGY
- Lipidomics applications in health, disease and nutrition research
- (2013) Sharon A. Murphy et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy—A meta-analysis of 11 randomized controlled trials involving 21,295 participants
- (2013) Marcin Barylski et al. PHARMACOLOGICAL RESEARCH
- STATISTICAL METHODS FOR THE ANALYSIS OF HIGH-THROUGHPUT METABOLOMICS DATA
- (2013) Jörg Bartel et al. Computational and Structural Biotechnology Journal
- CKD and Sudden Cardiac Death: Epidemiology, Mechanisms, and Therapeutic Approaches
- (2012) I. R. Whitman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Chronic Inflammatory Disorders and Accelerated Atherosclerosis: Chronic Kidney Disease
- (2011) Kaveh D. Navab et al. CURRENT PHARMACEUTICAL DESIGN
- Associations between Small Dense LDL, HDL Subfractions (HDL2, HDL3) and Risk of Atherosclerosis in Japanese-Americans
- (2011) Shusaku Maeda et al. Journal of Atherosclerosis and Thrombosis
- Clinical implications of discordance between low-density lipoprotein cholesterol and particle number
- (2011) James D. Otvos et al. Journal of Clinical Lipidology
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
- (2011) Charles A. Herzog et al. KIDNEY INTERNATIONAL
- Systems biology of kidney diseases
- (2011) John Cijiang He et al. KIDNEY INTERNATIONAL
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Metabolomics in the study of kidney diseases
- (2011) Robert H. Weiss et al. Nature Reviews Nephrology
- Lipid Abnormalities and Oxidized LDL in Chronic Kidney Disease Patients on Hemodialysis and Peritoneal Dialysis
- (2011) Elisabeth C. Samouilidou et al. RENAL FAILURE
- Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study
- (2010) Mireia Junyent et al. BMC Nephrology
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors
- (2007) A Negre-Salvayre et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search